Collegium Pharmaceutical, Inc.
COLL • NASDAQ
Collegium Pharmaceutical, Inc. is a drug manufacturers - specialty & generic company in the healthcare sector trading on NASDAQ, led by CEO Vikram Karnani, with a market cap of $1.1B.
Market Cap$1.1B
Employees197.0
CEOVikram Karnani
CountryUnited States of America
Healthcare
Drug Manufacturers - Specialty & Generic
Next EarningsMay 7, 2026 · In 3 weeksQ1 2026
Financials
Collegium Pharmaceutical, Inc. FAQ
Common questions about Collegium Pharmaceutical, Inc.
Collegium Pharmaceutical, Inc. is scheduled to report earnings for Q1 2026 on May 7, 2026. Analysts estimate revenue of $187.2M.
Collegium Pharmaceutical, Inc. has approximately 197 employees.